Capital Inc. Bioengine serves as Executive at WINDTREE THERAPEUTICS INC /DE/, where they oversee executive responsibilities. Since joining the company, Capital Inc. Bioengine has executed 3 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2021 involved selling 1,239,088 shares valued at $2.0M.
Capital Inc. Bioengine currently holds 1,239,088 shares of WINDTREE THERAPEUTICS INC /DE/ (WINT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Inc. Bioengine has been a net seller of WINT stock. They have purchased $400.0K and sold $2.0M worth of shares.
Capital Inc. Bioengine's most recent insider trade was on Dec 30, 2021, when they sold 1,239,088 shares at $1.60 per share.
Get notified when new Form 4 filings are submitted
| $7.25 |
| Discretionary |
| May 20, 2020 | WINT | $0 | Other | 3,551,750 | $N/A | Discretionary |